Neuro Peptide Telehealth
Physician-guided evaluation for peptide therapies studied in cognitive signaling, stress response, and sleep-related pathways.
$99 Consultation | $300 for Peptides if prescribed
Understanding Neuro Peptides
Neuro peptides are compounds studied for their influence on signaling pathways within the nervous system.
Through telehealth, licensed medical providers evaluate whether these therapies may be appropriate based on individual medical history and clinical judgment.
Compounded peptide medications are not FDA-approved for the diagnosis, treatment, cure, or prevention of disease.
Peptides in This Category
These therapies are often discussed by individuals interested in structured evaluation for stress-response and cognitive-signaling support.
Clinical evaluation determines whether DSIP-based therapy may be appropriate.
Appropriateness for therapy is determined only after physician consultation.
Who Typically Explores Neuro Peptide Telehealth?
- Maintain active lifestyles or demanding schedules
- Prioritize cognitive performance and mental clarity
- Experience inconsistent sleep patterns
- Prefer physician-guided oversight rather than self-directed supplementation
- Want structured, regulated access through licensed pharmacies
Eligibility for therapy is determined only after medical consultation.
How It Works
You’ll begin with a brief virtual consultation with a licensed medical provider, who will review your medical history and determine whether this therapy may be appropriate for you.
If treatment is recommended, your prescription is sent to a licensed U.S. compounding pharmacy and shipped directly to your home, typically within 3–7 business days.
Consultation Cost
The total cost is $99 for consultation. Peptides are additional.
If a peptide therapy is not clinically appropriate, there is no charge for the visit.
- All therapies are prescribed only when clinically appropriate and based on physician evaluation.
Medical & Regulatory Considerations
Neuro peptide therapies offered through telehealth may involve compounded formulations.
- Are not FDA-approved
- May have limited long-term safety data
- Are prescribed only under physician supervision
Certain peptides discussed in cognitive or sleep-related contexts may be considered investigational.
All prescribing decisions are based on individualized clinical evaluation.
Statements on this website have not been evaluated by the FDA.
Individual results vary.
- Peptide Disclaimer
- The peptide therapies discussed on this website are compounded medications prescribed by licensed medical providers when clinically appropriate. Many compounded peptides, including but not limited to BPC-157, TB-500, CJC-1295, Ipamorelin, GHK-Cu, MOTS-C, Selank, Semax, and similar therapies, have not been approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, cure, or prevention of disease.
- Information provided on this website is intended for educational and informational purposes only and should not be interpreted as medical advice, efficacy claims, or guarantees of outcome. Discussions regarding peptides may reference preclinical, investigational, anecdotal, or emerging research, including animal studies, laboratory data, and limited human experience. Human clinical evidence for many peptide therapies remains limited.
- Statements on this website have not been evaluated by the FDA. Individual results may vary. No claims are made regarding the safety, effectiveness, or superiority of any compounded peptide therapy.
- All treatment decisions are made solely at the discretion of a licensed healthcare provider after review of a patient’s medical history, medications, contraindications, and clinical appropriateness. Certain therapies may not be appropriate for individuals with specific medical conditions, including but not limited to cancer, cardiovascular disease, endocrine disorders, pregnancy, or other health concerns.
- Compounded medications are prepared by licensed compounding pharmacies and are not FDA-approved products. Patients should discuss all risks, benefits, alternatives, and uncertainties with their healthcare provider before beginning treatment.
Frequently Asked Questions
Many compounded peptide therapies are not FDA-approved for specific indications.
These therapies are not marketed as treatments for medical conditions. Providers evaluate each patient individually for clinical appropriateness.
No. Prescriptions are issued only after physician evaluation and approval.
Additional peptides may be considered after the first month when clinically appropriate and reviewed by your provider.
Interested in Neuro Peptide Telehealth?
Schedule your $99 physician consultation today.
Structured. Transparent. Physician-led.
